Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma-a promising innovative approach.
Saved in:
| Title: | Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma-a promising innovative approach. |
|---|---|
| Authors: | Gesundheit B; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Brauns C; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Vogl TJ; Department of Radiology and Nuclear Medicine, Frankfurt University Hospital, Frankfurt am Main, Germany., Muckenhuber A; Institute of Pathology, Technical University of Munich, Munich, Germany., Weisslein C; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Schmoll H; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Ellis R; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Posen Y; Research and Development, RapoYerape Ltd., Jerusalem, Israel., Raju JS; Research and Development, RapoYerape Ltd., Jerusalem, Israel. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Aug 07; Vol. 15, pp. 1631155. Date of Electronic Publication: 2025 Aug 07 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
